EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?

David J Wright iD, María Emilce Trucco iD, Jiani Zhou iD, Claudia Wolff iD, Reece Holbrook iD, Jamie Margetta iD, Mikhael F El-Chami iD

Europace · 02.07.2024 · 26 (7)

DOI: 10.1093/europace/euae169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Europace, online erschienen am 19.06.2024. Verfasst von David J Wright und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Liverpool Heart and Chest Hospital, Liverpool, UK. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Defibrillators, Implantable, Disease Progression, Prosthesis-Related Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac implantable electronic device (CIED) infections are a burden to hospitals and costly for healthcare systems. Chronic kidney disease (CKD) increases the risk of CIED infections, but its differential impact on healthcare utilization, costs, and outcomes is not known. Methods and results This retrospective analysis used de-identified Medicare Fee-for-Service claims to identify patients implanted with a CIED from July 2016 to December 2020. Outcomes were defined as hospital days and costs within 12 months post-implant, post-infection CKD progression, and mortality. Generalized linear models were used to calculate results by CKD and infection status while controlling for other comorbidities, with differences between cohorts representing the incremental effect associated with CKD. A total of 584 543 patients had a CIED implant, of which 26% had CKD and 1.4% had a device infection. The average total days in hospital for infected patients was 23.5 days with CKD vs. 14.5 days (P < 0.001) without. The average cost of infection was $121 756 with CKD vs. $55 366 without (P < 0.001), leading to an incremental cost associated with CKD of $66 390. Infected patients with CKD were more likely to have septicaemia or severe sepsis than those without CKD (11.0 vs. 4.6%, P < 0.001). After infection, CKD patients were more likely to experience CKD progression (hazard ratio 1.26, P < 0.001) and mortality (hazard ratio 1.89, P < 0.001).

Conclusion

Cardiac implantable electronic device infection in patients with CKD was associated with more healthcare utilization, higher cost, greater disease progression, and greater mortality compared to patients without CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicDefibrillators, ImplantableDisease ProgressionProsthesis-Related InfectionsPacemaker, ArtificialHumansMaleFemaleRetrospective StudiesAgedUnited StatesAged, 80 and overHealth Care CostsMedicarePatient Acceptance of Health CareLength of Stay

Stichwörter der Autor:innen

CIED infectionChronic kidney diseaseCostsDisease progressionHealthcare resourcesMortality

Autor:innen und Institutionen

  • Cardiology Division, Liverpool Heart and Chest Hospital, Liverpool, UK.
  • Arrhythmia Section, Cardiology Department, Hospital Universitari Doctor Josep Trueta and Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain.
  • Cardiac Rhythm Management, Medtronic plc, 8200 Coral Sea Street, MVC71 Mounds View, MN 55112, USA.
  • Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
  • Department of Medicine, Division of Cardiology, Emory University Hospital, Atlanta, GA, USA.

ORCID-Profile: David J Wright, María Emilce Trucco, Jiani Zhou, Claudia Wolff, Reece Holbrook, Jamie Margetta, Mikhael F El-Chami

Förderung

  • Medtronic

Zitieren

APA

Wright, D. J., Trucco, M. E., Zhou, J., Wolff, C., Holbrook, R., Margetta, J., & El-Chami, M. F. (2024). Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?. Europace, 26(7). https://doi.org/10.1093/europace/euae169

Vancouver

Wright DJ, Trucco ME, Zhou J, Wolff C, Holbrook R, Margetta J, et al. Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?. Europace. 2024;26(7). doi:10.1093/europace/euae169

BibTeX
@article{Wright2024,
  author = {Wright, David J and Trucco, María Emilce and Zhou, Jiani and Wolff, Claudia and Holbrook, Reece and Margetta, Jamie and El-Chami, Mikhael F},
  title = {Chronic kidney disease and transvenous cardiac implantable electronic device infection—is there an impact on healthcare utilization, costs, disease progression, and mortality?},
  journal = {Europace},
  year = {2024},
  volume = {26},
  number = {7},
  doi = {10.1093/europace/euae169}
}
Kostenlos starten →